Search clinical trials for: Rotavirus vaccine

Total 10027 results

University of Oxford

Completed

Rotavirus Vaccine in Premature Babies (RotaNeo)

Gastroenteritis

United Kingdom
Dennis Clements
Merck Sharp & Dohme LLC

Completed

An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)

Gastroenteritis | Diarrhea

United States
Merck Sharp & Dohme LLC

Completed

Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)

Gastroenteritis | Rotavirus
Merck Sharp & Dohme LLC

Completed

Developing World Study for RotaTeq™ (V260-015)(COMPLETED)

Vomiting | Diarrhea | Fever
Merck Sharp & Dohme LLC

Completed

Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)

Gastroenteritis | Rotavirus
GlaxoSmithKline

Completed

Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines

Infections, Rotavirus

Czech Republic
GlaxoSmithKline

Completed

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Infections, Rotavirus

Finland, Germany, Spain, Italy, France, Czech Republic
Academisch Medisch Centrum - Universiteit van Amsterdam...
University of Padova; Centers for Disease Control and Prevention; Aga Khan University and other collaborators

Completed

The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan

Rotavirus

Pakistan
GlaxoSmithKline

Completed

Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants

Rotavirus Gastroenteritis

Thailand
University of Tartu

Unknown

The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines (ERVS)

Rotavirus Infection

Estonia
GlaxoSmithKline

Completed

Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)

Infections, Rotavirus

Singapore
GlaxoSmithKline

Completed

Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants

Infections, Rotavirus

South Africa, Malawi
GlaxoSmithKline

Completed

A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

Infections, Rotavirus

Singapore
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

Infections, Rotavirus

United States
GlaxoSmithKline

Completed

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

Infections, Rotavirus

Finland
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

Infections, Rotavirus

Argentina, Brazil, Dominican Republic, Panama, Colombia, Honduras
GlaxoSmithKline

Completed

To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)

Infections, Rotavirus

Vietnam
GlaxoSmithKline

Completed

Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Infections, Rotavirus

Korea, Republic of
GlaxoSmithKline

Completed

A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh

Infections, Rotavirus

Bangladesh
GlaxoSmithKline

Completed

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Infections, Rotavirus

Finland
GlaxoSmithKline

Completed

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants

Hepatitis B
GlaxoSmithKline

Completed

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants

Infections, Rotavirus
GlaxoSmithKline

Completed

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

Infections, Rotavirus
GlaxoSmithKline

Completed

Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa

Infections, Rotavirus

South Africa
GlaxoSmithKline

Completed

To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV

Rotavirus Infections

South Africa
GlaxoSmithKline

Completed

Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine

Infections, Rotavirus

Mexico, Colombia, Peru
National Institute of Hygiene and Epidemiology,...
Center for Research and Production of Vaccines and Biologicals

Completed

Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults

Nausea | Diarrhea | Fever | Vomit | Irritability

Vietnam
McGill University Health Centre/Research Institute...
GlaxoSmithKline; Institut National en Santé Publique du Québec; Ministere de...

Completed

Vaccine Effectiveness of RV1 in a Naïve Population

Gastroenteritis | Diarrhea | Rotavirus Infections

Canada
Seattle Children's Hospital
National Center for Research Resources (NCRR); Thrasher Research Fund

Completed

Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure

Intestinal Failure | Rotavirus Vaccines

United States
Merck Sharp & Dohme LLC

Completed

A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)

Rotavirus Gastroenteritis
Merck Sharp & Dohme LLC

Withdrawn

A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)

Pertussis | Tetanus | Diphtheria | Rotavirus Gastroenteritis
Merck Sharp & Dohme LLC

Completed

V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)

Rotavirus Disease
Merck Sharp & Dohme LLC

Completed

Consistency Lots Vaccine Study (V260-009)

Rotavirus Infections
Merck Sharp & Dohme LLC

Completed

Dose Confirmation Efficacy Study (V260-007)

Rotavirus Infections
PATH
Centers for Disease Control and Prevention; Noguchi Memorial Institute for... and other collaborators

Completed

Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana

Rotavirus Gastroenteritis

Ghana
Merck Sharp & Dohme LLC

Terminated

A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)

Rotavirus
University of Vermont
Washington University School of Medicine; Bill and Melinda Gates Foundation; Stanford... and other collaborators

Completed

Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh (PROVIDE)

Vaccine Virus Shedding | Tropical Enteropathy | Rotavirus Diarrhea

Bangladesh
GlaxoSmithKline

Completed

Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™

Infections, Rotavirus
Merck Sharp & Dohme LLC

Completed

V260 Registration Study (V260-013)(COMPLETED)

Rotavirus
Merck Sharp & Dohme LLC

Completed

Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)

Gastroenteritis | Rotavirus Infections
GlaxoSmithKline

Withdrawn

Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine

Infections, Rotavirus
Merck Sharp & Dohme LLC

Terminated

Gastroenteritis From Rotavirus Infection in Brazilian Children Less Than 5 Years of Age (Study V260-031).

Pediatric Gastroenteritis
GlaxoSmithKline

Withdrawn

Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis

Infections, Rotavirus
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules

Rotavirus Infection

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
University of Padova; Centers for Disease Control and Prevention; Aga Khan University and other collaborators

Completed

Does the Fecal Microbiome Influence Rotarix Immunogenicity

Rotavirus Infections | Reaction - Vaccine Nos | Intestinal Bacteria Flora Disturbance
Anna Taddio

Unknown

Rotavirus vs. Sucrose for Vaccine Injection Pain

Vaccination Pain Management

Canada
Children's Hospital of Michigan
Merck Sharp & Dohme LLC; Boston Children's Hospital; William Beaumont Hospitals

Completed

Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome

Short Bowel Syndrome

United States
Sichuan Center for Disease Control and Prevention
China National Biotec Group Company Limited

Unknown

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

Rotavirus
Novartis Vaccines

Completed

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Meningitis, Meningococcal

United States, Argentina, Colombia
University Hospital, Brest
MCM Vaccines B.V.

Completed

Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France. (IVANHOE)

Rotavirus Gastroenteritis

France

3

Subscribe